Literature DB >> 111683

Effects of anticalcifying and antifibrobrotic drugs on pre-established atherosclerosis in the rabbit.

W Hollander, J Paddock, S Nagraj, M Colombo, B Kirkpatrick.   

Abstract

The effects of the anticalcifying drug, ethane-hydroxydiphosphonate (EHDP) and the inhibitors of collagen biosynthesis, colchicine, penicillamine and azetidine were studied in the rabbit with pre-established atherosclerosis. The drugs were administered with a cholesterol-free diet (regression diet) for 8 weeks following the induction of atherosclerosis by feeding a hypercholesterolemic diet containing 2% cholesterol and 8% peanut oil for 8 weeks. The extent and severity of aortic atherosclerosis, as revealed by the morphological and biochemical findings, increased significantly during the regression period. In rabbits treated with EHDP (5 mg/kg/day) the aorta had fewer gross lesions and contained significantly less cholesterol, collagen and elastin than did the aorta of the rabbits fed the regression diet alone. These changes were associated with a significant reduction in aortic calcium caused by EHDP. The aortic content of cholesterol, collagen and elastin in the EHDP-treated rabbits, although less than that of the rabbits fed the regression diet alone, was about the same as that of the rabbits fed a high cholesterol diet for 8 weeks. Both colchicine (0.2 mg/kg/day) and penicillamine (100 mg/kg/day) had a selective action on the induced plaques in that they suppressed the fibrous proliferation in the lesions without preventing lipid and calcium accumulation in the lesions. Neither colchicine nor penicillamine reduced the extent of aortic atherosclerosis as determined by gross examination of the vessel. Azetidine had no significant effect on the pre-established atherosclerotic lesions. The lipid, fibrous protein and calcium content of the aorta of the azetidine-treated animals was not significantly different from that of the untreated animals. The biochemical findings in the aorta were consistent with the microscopic changes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111683     DOI: 10.1016/0021-9150(79)90202-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

Review 1.  Influence of nifedipine on experimental arteriosclerosis.

Authors:  A M Knorr; S Kazda
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Effect of ethane-I-hydroxy-I, I-diphosphonate on arterial calcinosis induced by hypervitaminosis D: a morphologic investigation.

Authors:  J G Kingma; P E Roy
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

3.  Effect of etidronic acid on arterial calcification in dialysis patients.

Authors:  Tsuneo Ariyoshi; Kiyoyuki Eishi; Ichiro Sakamoto; Seiji Matsukuma; Tomohiro Odate
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

4.  Isradipine improves platelet function in hypertensives.

Authors:  H Sinzinger; I Virgolini; F Rauscha; P Fitscha; J O'Grady
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.

Authors:  P D Henry; K I Bentley
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

6.  International nifedipine trial on antiatherosclerotic therapy (INTACT).

Authors:  P R Lichtlen; U Nellessen; W Rafflenbeul; S Jost; H Hecker
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

Review 7.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

Review 8.  Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?

Authors:  Samy I McFarlane; Ranganath Muniyappa; John J Shin; Gul Bahtiyar; James R Sowers
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

9.  Bisphosphonates and risk of cardiovascular events: a meta-analysis.

Authors:  Dae Hyun Kim; James R Rogers; Lisa A Fulchino; Caroline A Kim; Daniel H Solomon; Seoyoung C Kim
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

10.  Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress.

Authors:  Vaios Vasileios Kaminiotis; George Agrogiannis; Panagiotis Konstantopoulos; Vasiliki Androutsopoulou; Laskarina Maria Korou; Ioannis S Vlachos; Ismene A Dontas; Despina Perrea; Dimitrios C Iliopoulos
Journal:  Lipids Health Dis       Date:  2017-09-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.